Timothy P. Lynch, Director at NABI BIOPHARMACEUTICALS (NABI), sold 3,846 shares at $5.20 ($20K) on 2009-11-17, disclosed to the SEC on 2009-11-18.
Open-market sale of $20k NABI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.